Healthcare -
Biotechnology - NASDAQ - US
$ 8.195
-1.62 %
$ 1.32 B
Market Cap
-3.76
P/E
NVAX - REVENUE
Revenue NVAX - Novavax, Inc.
556 M
LAST VALUE
-30.33%
2 YEAR CAGR
74.60%
5 YEAR CAGR
38.83%
10 YEAR CAGR